Fierce Healthcare
JANUARY 16, 2025
UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior. | UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior.
Drug Topics
JANUARY 17, 2025
Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 14, 2025
For the second time in less than a year, the U.S. Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs.
The Checkup by Singlecare
JANUARY 14, 2025
If youre living with diabeteswhether prediabetes , Type 2 diabetes , or Type 1 diabetes then youre probably taking steps to manage your blood glucose levels. Along with regular exercise, sufficient sleep, and taking care of your mental health, following a healthy, balanced meal plan is one of the most effective components of diabetes management. As you focus on maintaining healthy blood sugar levels, being mindful of your carbohydrate intake is likely at the forefront of your mind.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
JANUARY 14, 2025
Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.
Drug Topics
JANUARY 16, 2025
Researchers compared the safety and reactogenicity of simultaneous doses of recombinant zoster vaccine paired with 2 separate types of inactivated influenza vaccines.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Checkup by Singlecare
JANUARY 16, 2025
If Repatha were ever to leave the market, there are other, non-statin medications doctors can use. Some options include : Repatha (evolocumab) is a brand-name medication that is FDA approved to lower cholesterol and reduce the risk of heart attacks and strokes, by helping to restore blood flow to the heart in individuals with heart disease. Similar to statins, Repatha is a cholesterol-lowering prescription drug.
PharmaVoice
JANUARY 15, 2025
CMS is expected to publish up to 15 drugs for the second cycle of the program by Feb. 1, and these are some of the drugs most likely to make the list.
Drug Topics
JANUARY 17, 2025
A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.
STAT
JANUARY 15, 2025
Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P. Morgan Healthcare conference, the announcements include $245 million for Innovaccer, a health care data company that’s increasingly focused on AI, $141 million for Hippocratic AI, a company that develops generative AI agents to help with clinical tasks, and $105 mill
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
JANUARY 15, 2025
If youre looking to reduce your body weight and body mass index (BMI), your healthcare provider may prescribe a GLP-1 medication, such as Wegovy (semaglutide), as part of your weight-loss program. However, due to a national shortage of Wegovy and Ozempic (the Type 2 diabetes treatment with the same active ingredient), patients are looking for alternatives.
Med Ed 101
JANUARY 12, 2025
Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. Understanding possible drug-drug and drug-disease interactions between medications is extremely important for optimizing medication therapy, preventing adverse effects, and overall improving patient outcomes in diabetes patients.
Drug Topics
JANUARY 15, 2025
The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.
STAT
JANUARY 13, 2025
Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will provide a boost as the industry gathers for one of its largest events of the year. With the acquisition, the pharma giant will get Intra-Cellular’s Caplyta, which is approved to treat schizophrenia and bipolar-related depression.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Guardian - Pharmaceutical Industry
JANUARY 11, 2025
The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe Tucked away in the village of Leasowe, near Moreton on the Wirral peninsula west of Liverpool, the US pharmaceutical company Bristol Myers Squibb (BMS) is building a new 35m glass-clad laboratory building. It is part of a growing life sciences cluster in and around Liverpool , one of the largest in Europe, and a leader in vaccine development and manufacture, as well as infectious d
PharmaVoice
JANUARY 16, 2025
The J.P. Morgan Healthcare Conference has been a focal point for M&A year after year, and after a quiet period, the deals are back on the table.
Drug Topics
JANUARY 15, 2025
There are a lack of data available on the optimal antiviral medication for nonsevere flu.
STAT
JANUARY 16, 2025
SAN FRANCISCO — One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui Pharmaceuticals, emphasized its global ambitions and plans for more dealmaking at a presentation at the J.P. Morgan Healthcare Conference Thursday. “In the last two decades, [Hengrui] has grown from a China-focused generics company to one of the largest innovative medicine companies in the world,” the company’s chief strategy officer, Frank Jiang, said at
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
DiversifyRx
JANUARY 16, 2025
Growing and retaining your non-PBM revenue is one of the keys to success in 2024 and beyond. Non-PBM revenue has become a cornerstone for independent pharmacies striving to maintain profitability and thrive in an industry dominated by Pharmacy Benefit Managers (PBMs). By diversifying income streams beyond PBM reimbursements, pharmacies can achieve greater financial stability and deliver enhanced value to their communities.
Pharma Marketing Network
JANUARY 11, 2025
Table of Contents Sr# Headings 1 Introduction: The Power of SEO Campaigns in Pharma Marketing 2 Crafting an Effective SEO Strategy for Pharma Marketing 3 Leveraging Content Marketing in SEO Campaigns 4 Measuring Success and Optimizing SEO Campaigns Introduction: The Power of SEO Campaigns in Pharma Marketing In todays competitive digital landscape, SEO campaigns have become an indispensable tool for pharma marketing executives.
Drug Topics
JANUARY 14, 2025
Rates of chlamydia and syphilis declined in adults taking HIV PrEP.
STAT
JANUARY 15, 2025
In May 2024 , nearly 90% of pharmacies were closed for a day as thousands of pharmacists protested over “over drug shortages, pharmacy closures and fears medications could be sold online, as well as higher pay.” More recently in November 2024 , pharmacy owners voted in favor of cutting hours and stopping home deliveries in a protest over funding.
Pharmafile
JANUARY 14, 2025
Pharmapack Europe: Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and existing biomedical research infrastructure 18 December 2024 Paris, France New research released ahead of Pharmapack Europe the continents largest partnering event for medical device and packaging innovation has ranked the Basel region […] The post Switzerlands Basel Region Crowned Europes Top Destination to Launch a Drug Device Company, According to Ph
PharmaVoice
JANUARY 14, 2025
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.
Drug Topics
JANUARY 16, 2025
Known as The Nutrition Pharmacist, Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.
STAT
JANUARY 13, 2025
Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project , a database of genetic data that is expected to accelerate personalized medicine and help discover new drugs. Truveta plans to use leftover biospecimens from patients — after they consent — receiving routine health care at participating health systems to create the database.
Pharmacy Times
JANUARY 17, 2025
If finalized, the requirement would include readily available nutrition information, including saturated fat, sodium, and added sugar content.
PharmaVoice
JANUARY 13, 2025
The first draft guidance provides an initial framework for how the agency will assess AI models in drug development, but the industry is still looking for more.
Drug Topics
JANUARY 14, 2025
RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.
STAT
JANUARY 15, 2025
SAN FRANCISCO — Are we entering a world in which all of the exciting new therapeutics come from China? That question and variations of it could be heard at coffee meetings and late-night cocktail parties this week during the J.P. Morgan Healthcare Conference. Just days before planes full of biopharma executives and investors touched down in San Francisco, a flurry of companies launched with drug candidates from China.
Pharma Marketing Network
JANUARY 11, 2025
Table of Contents Sr# Headings 1 Introduction: The Power of Pharmaceutical Advertising 2 Crafting Effective Pharmaceutical Advertising Campaigns 3 Navigating Regulations in Pharma Advertising 4 Leveraging Technology and Trends in Pharma Marketing Introduction: The Power of Pharmaceutical Advertising Pharmaceutical advertising plays a pivotal role in shaping healthcare decisions, bridging the gap between pharma companies, healthcare providers, and patients.
PharmaVoice
JANUARY 13, 2025
Companies are looking to new countries like Vietnam for manufacturing needs, but change comes at a cost.
Drug Topics
JANUARY 13, 2025
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.
Expert insights. Personalized for you.
137 
Let's personalize your content